Welcome to the official website of Unipharm pharmaceutical industry Co., Ltd.!
Focus on research and development of new active pharmaceutical ingredients, pharmaceutical intermediates, APIs and other specialty chemicals
Pharmaceutical Intermediates Heterocyclic Block Organic Block
Home> Pharmaceutical Intermediates>Antineoplastic Agents> Rigsett Intermediate
Regent Is An Atp Non-Competitive Plk1 Inhibitor With An Ic50 Value Of 9 Nm And A Selectivity Of More Than 30 Times That Of Plk2. It Is A Phase Iii Clinical Trial Developed By Onconova For The Treatment Of Chronic Myelomonocytic Leukemia.
No data